Search Within

Adilia Hormigo

Formats
  1. Meeting Abstract (25)
  2. Journal Article (23)
  3. Book Section (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (28)
  2. Biostatistics Service (16)
  3. Epidemiology and Biostatistics (16)
  4. Population Sciences Research Program (16)
  5. Radiology, Department of (12)
  6. Surgery (12)

More Groups

People
  1. Lisa De Angelis (28)
  2. Lauren Abrey (21)
  3. Andrew Lassman (16)
  4. Katherine Panageas (16)
  5. Igor Gavrilovic (14)
  6. Craig Nolan (13)

More People

Years
  1. 2016 (1)
  2. 2014 (1)
  3. 2013 (2)
  4. 2012 (1)
  5. 2011 (9)
  6. 2010 (2)

More Years

Publications
  1. Neuro-Oncology (17)
  2. Journal of Clinical Oncology (12)
  3. Journal of Neuro-Oncology (5)
  4. Clinical Cancer Research (3)
  5. Annals of Neurology (2)
  6. Archives of Neurology (1)

More Publications

Publishers
  1. Oxford University Press (17)
  2. American Society of Clinical Oncology (12)
  3. Springer (6)
  4. American Association for Cancer Research (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A longitudinal prospective study of YKL-40 and matrix metalloproteinase-9 (MMP-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; Holland, E.; DeAngelis, L. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Meeting Abstract

    Ney, D.; DeAngelis, L.; Nolan, C.; Gavrilovic, I.; Hormigo, A.; Lassman, A.; Abrey, L.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Ykl-40 and matrix metalloproteinase-9 (Mmp-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F.; Hottinger, A.; Jahdi, M.; Dantis, J.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Cd133+expression in the brain and high-grade glioma of a mouse model with a lacz reporter knock-in at the Cd133 locus
    Meeting Abstract

    Hormigo, A.; Shmelkov, S.; Hooper, A.; Butler, J.; James, D.; Hambardzumyan, D.; Becher, O.; Holland, E. C.; Rafii, S.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
    Journal Article

    Iwamoto, F. M.; Omuro, A. M.; Raizer, J. J.; Nolan, C. P.; Hormigo, A. L.; Lassman, A. B.; Gavrilovic, I. T.; Abrey, L. E.
    Journal of Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas
    Journal Article

    Iwamoto, F. M.; Nicolardi, L.; Demopoulos, A.; Barbashina, V.; Salazar, P.; Rosenblum, M.; Hormigo, A.
    Journal of Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II trial of temozolomide and vinorelbine for patients with recurrent brain metastases
    Meeting Abstract

    Iwamoto, F. M.; Omuro, A. M.; Raizer, J. J.; Nolan, C. P.; Hormigo, A.; Lassman, A. B.; Gavrilovic, I. T.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The effect of corticorelin acetate on peritumoral brain edema: An interim report of an open-label study as part of a phase III program
    Meeting Abstract

    Carr, L.; Mechtler, L.; Recht, L.; Hormigo, A.; Paleologos, N.; Alksne, J. F.; Arenson, E.; Raizer, J.; Shulman, M. G.; for the CAPBrainEdema [Corticorelin Acetate Peritumoral Brain Edema] Study Group
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term safety and steroid-sparing potential of corticorelin acetate injection for treatment of peritumoral brain edema: Third interim report of an open-label study as part of a phase III program
    Meeting Abstract

    Recht, L.; Mechtler, L.; Alksne, J.; Arenson, E.; Paleologos, N.; Avgeropoulos, N.; Hormigo, A.; Perry, J.; Raizer, J.; Robins, H. I.; more...
    Neuro-Oncology (2007)

    Fulltext@MSK | Save